New product: Polivy (polatuzumab vedotin) 140 mg powder for concentrate for solution for infusion

This product is licensed for use in combination with bendamustine and rituximab for the treatment of adult patients with relapsed/refractory diffuse large B-cell lymphoma who are not candidates for haematopoietic stem cell transplant.

electronic Medicines compendium